The Fanatec ClubSport GT Cockpit certainly looks the part, and the good news is that its feature set, ease of use and overall ...

Street-legal does not mean slow. These machines deliver huge horsepower, sharp aero, and massive top speeds that feel closer to race cars than daily drivers.

From racing legends to road-going terrors, these iconic cars earned nicknames that perfectly captured their personality, ...

Australia's CSL is wielding the axe, cutting its workforce by 15% – around 3,000 positions – while announcing plans to spin its vaccines unit into a standalone company. The decision to demerge the CSL ...

CSL Limited trades at a decade-low P/E, despite ongoing revenue and profit growth, presenting significant upside potential. CSL's vaccine business volatility and slow margin recovery, especially at ...

Australian pharmaceuticals heavyweight CSL has announced its chief executive Dr Paul McKenzie is retiring with immediate effect, as the company tries to rebuild confidence among investors following a ...

CSL has dumped chief executive Paul McKenzie after a brutal year for the global biotechnology giant, installing a former senior manager as interim boss following pressure from shareholders for a ...

Given its struggles over the past couple of years, it has been tempting to sell CSL Ltd (ASX: CSL) shares on numerous occasions. However, I'm hoping to never sell the biotechnology giant's shares. The ...

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst ...

Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE. If you are wondering whether ...

In the latest escalation of the long-running dispute, up to 1270 workers will walk out of CSL’s Melbourne office, expressing anger at management’s response to union members voting down the company’s ...

CSL Behring's Andembry can be used to prevent recurrent attacks of hereditary angioedema (HAE) by the NHS, according to finalised guidance from reimbursement authority NICE. The just-published ...